Search Results 1921-1930 of 7281 for albumin
DEAR MAYO CLINIC: I have high blood pressure and was just diagnosed as having chronic kidney disease. I am disheartened by this news, but I[...] ...
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
Sherman EJ, Harris J, Bible KC, Xia P, Ghossein RA, Chung CH, Riaz N, Gunn GB, Foote RL, Yom SS, Wong SJ, Koyfman SA, Dzeda MF, Clump DA, Khan SA, Shah MH, ...
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine. Donate · Find a doctor · Explore careers.
Rochester, Minn. The purpose of this study is to evaluate the magnitude of financial toxicity in newly diagnosed and relapsed multiple myeloma (MM) and ...
Rochester, Minn. The purpose of this study is to estimate the circulating tumor DNA (ctDNA)detection rate and mutational load in breast cancer patients with ...
A cancer diagnosis can turn your life upside down. An unknown future, unexpected setbacks and unanswered questions loom ahead for the recently diagnosed patient ...
Title: DTRM-555_001, Phase II Expansion Cohorts Studies of a Novel Triple Combination Therapy, DTRM-555, in Patients with Relapsed/Refractory Chronic ...
Title: Pilot Study of Ponatinib in Biliary Cancer Patients With FGFR2 Fusions · Title: A Phase I, Multicenter, Open-label, Dose-Escalation, Safety, ...
The purpose of this study is to evaluate how children and young adults perceive their midline sternotomy scars (in terms of appearance, associated symptoms, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.